Personal tools

MCL coexpression mm9:2832: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000073!7.18e-23!54;UBERON:0002346!1.25e-21!64;UBERON:0003075!1.25e-21!64;UBERON:0007284!1.25e-21!64;UBERON:0001049!2.13e-21!52;UBERON:0005068!2.13e-21!52;UBERON:0006241!2.13e-21!52;UBERON:0007135!2.13e-21!52;UBERON:0001017!3.80e-21!73;UBERON:0001016!5.35e-20!75;UBERON:0002020!4.50e-19!34;UBERON:0010371!9.55e-19!73;UBERON:0003056!1.78e-18!49;UBERON:0000955!5.05e-18!47;UBERON:0006238!5.05e-18!47;UBERON:0004121!1.61e-17!95;UBERON:0000924!1.61e-17!95;UBERON:0006601!1.61e-17!95;UBERON:0002616!2.44e-17!46;UBERON:0003080!6.64e-17!40;UBERON:0002780!2.31e-16!39;UBERON:0001890!2.31e-16!39;UBERON:0006240!2.31e-16!39;UBERON:0003528!1.88e-15!29;UBERON:0002791!1.88e-15!29;UBERON:0001893!1.88e-15!29;UBERON:0010314!2.15e-13!92;UBERON:0000956!3.19e-11!21;UBERON:0001869!3.19e-11!21;UBERON:0000203!3.19e-11!21;UBERON:0000468!8.10e-10!333;UBERON:0002619!4.75e-09!17;UBERON:0000922!4.46e-08!320;UBERON:0002021!4.08e-07!10;UBERON:0000411!4.08e-07!10;UBERON:0001950!4.08e-07!10
|ontology_enrichment_uberon=UBERON:0000073!7.18e-23!54;UBERON:0002346!1.25e-21!64;UBERON:0003075!1.25e-21!64;UBERON:0007284!1.25e-21!64;UBERON:0001049!2.13e-21!52;UBERON:0005068!2.13e-21!52;UBERON:0006241!2.13e-21!52;UBERON:0007135!2.13e-21!52;UBERON:0001017!3.80e-21!73;UBERON:0001016!5.35e-20!75;UBERON:0002020!4.50e-19!34;UBERON:0010371!9.55e-19!73;UBERON:0003056!1.78e-18!49;UBERON:0000955!5.05e-18!47;UBERON:0006238!5.05e-18!47;UBERON:0004121!1.61e-17!95;UBERON:0000924!1.61e-17!95;UBERON:0006601!1.61e-17!95;UBERON:0002616!2.44e-17!46;UBERON:0003080!6.64e-17!40;UBERON:0002780!2.31e-16!39;UBERON:0001890!2.31e-16!39;UBERON:0006240!2.31e-16!39;UBERON:0003528!1.88e-15!29;UBERON:0002791!1.88e-15!29;UBERON:0001893!1.88e-15!29;UBERON:0010314!2.15e-13!92;UBERON:0000956!3.19e-11!21;UBERON:0001869!3.19e-11!21;UBERON:0000203!3.19e-11!21;UBERON:0000468!8.10e-10!333;UBERON:0002619!4.75e-09!17;UBERON:0000922!4.46e-08!320;UBERON:0002021!4.08e-07!10;UBERON:0000411!4.08e-07!10;UBERON:0001950!4.08e-07!10
|tfbs_overrepresentation_for_novel_motifs=0.752782,0.564138,0.722405,0.801166,0.587814,0.81763,0.919454,0.467321,0.479531,0.235304,0.870507,0.906098,1.18012,0.933025,0.608226,0,1.14208,0.578045,0.448066,0.876292,0.679146,0.756749,0.932027,0.585919,0.731217,0.963352,0.437236,1.96186,0.64294,0.380786,0.825437,1.24901,0.575271,1.86457,0.608816,0.444545,0.563758,0.902078,0.536514,0.50014,0.582863,0.831295,0.261619,0.610669,0.474221,0.788421,1.05665,0.859154,0.235354,0.646474,1.12346,0.99279,0.971403,1.3966,1.41464,0.940919,0.657156,0.891887,1.08907,0.938668,1.22795,1.00308,0.494668,1.11142,0.953187,1.15459,1.55483,1.90983,1.22303,1.7608,0.700291,0.474956,0.284975,1.44925,0.416814,1.83166,0.411601,1.04436,1.20986,0.684144,0.476502,1.16055,1.00151,0.459035,1.32978,2.30787,0.195254,0.380977,1.06194,2.07346,1.62608,1.33496,1.26245,0.595071,0.531443,0.509215,0.464141,1.26539,1.05692,0.352122,0.563856,1.24872,1.37854,1.12409,1.12297,0.830796,1.18646,0.854628,0.689894,0.681267,0.744607,1.38039,0.685481,2.03346,1.63327,0.580657,1.1471,0.805461,1.14346,0.559153,1.45481,1.08896,0.965352,1.04338,1.68841,1.21376,0.928483,1.25534,1.55328,0.598722,1.36093,0.792832,1.52297,0.955954,1.65529,0.751419,1.79943,0.832891,1.60513,2.44352,2.04137,1.55966,0.978551,1.26,2.52174,0.831808,1.06002,2.40374,0.765221,0.589976,0.999018,0.260379,1.39822,0.516739,0.954936,1.48249,0.993889,0.622823,0.749933,0.762177,1.61484,1.32889,1.21423,0.741984,1.11251,0.94678,0.562367,0.904334,1.34909
}}
}}

Revision as of 22:00, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr13:24373093..24373146,-p3@Lrrc16a
Mm9::chr13:24373161..24373194,-p4@Lrrc16a
Mm9::chr6:8898570..8898602,+p4@Nxph1


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
CNS neuron (sensu Vertebrata)2.79e-1523
neuroblast (sensu Vertebrata)2.79e-1523
neuron1.63e-1033
neuronal stem cell1.63e-1033
neuroblast1.63e-1033
electrically signaling cell1.63e-1033
ectodermal cell9.65e-0844
neurectodermal cell9.65e-0844
electrically responsive cell1.12e-0739
electrically active cell1.12e-0739
neural cell2.31e-0743

Uber Anatomy
Ontology termp-valuen
regional part of nervous system7.18e-2354
neurectoderm1.25e-2164
neural plate1.25e-2164
presumptive neural plate1.25e-2164
neural tube2.13e-2152
neural rod2.13e-2152
future spinal cord2.13e-2152
neural keel2.13e-2152
central nervous system3.80e-2173
nervous system5.35e-2075
gray matter4.50e-1934
ecto-epithelium9.55e-1973
pre-chordal neural plate1.78e-1849
brain5.05e-1847
future brain5.05e-1847
ectoderm-derived structure1.61e-1795
ectoderm1.61e-1795
presumptive ectoderm1.61e-1795
regional part of brain2.44e-1746
anterior neural tube6.64e-1740
regional part of forebrain2.31e-1639
forebrain2.31e-1639
future forebrain2.31e-1639
brain grey matter1.88e-1529
regional part of telencephalon1.88e-1529
telencephalon1.88e-1529
structure with developmental contribution from neural crest2.15e-1392
cerebral cortex3.19e-1121
cerebral hemisphere3.19e-1121
pallium3.19e-1121
multi-cellular organism8.10e-10333
regional part of cerebral cortex4.75e-0917
embryo4.46e-08320
occipital lobe4.08e-0710
visual cortex4.08e-0710
neocortex4.08e-0710


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}